Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Tables)

v3.22.0.1
STOCK COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Total Compensation Expense Recognized for Stock-Based Compensation Awards
The following table summarizes the total compensation expense recognized for stock-based compensation awards:
(In Millions, except per
share amounts)
Year Ended December 31,
  2021 2020 2019
Cost of goods sold $ (2) $ (2) $ (2)
Selling, general and administrative expenses (16) (13) (16)
Acquisition-related costs   (2) — 
Stock based compensation expense (18) (17) (18)
Income tax benefit 4 
Stock based compensation expense, net of tax $ (14) $ (13) $ (14)
Decrease in basic earnings per common share $ (0.03) $ (0.03) $ (0.05)
Decrease in diluted earnings per common share $ (0.03) $ (0.03) $ (0.05)
Summary of Performance Award Activity
The following table summarizes the performance award activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value
Outstanding at beginning of year 2,452,226  $ 10.34  1,935,878  $ 15.58  1,424,723  $ 14.46 
Granted 652,888  25.12  960,637  6.93  572,104  18.31 
Granted - replacement awards     1,550,216  4.59  —  — 
Distributed (1,279,509) 11.74  (1,938,786) 12.23  —  — 
Performance adjustment 625,355  11.93  549,154  15.63  —  — 
Forfeited/canceled (80,490) 11.27  (604,873) 5.70  (60,949) 15.12 
Outstanding at end of year 2,370,470  $ 14.04  2,452,226  $ 10.34  1,935,878  $ 15.58 
Summary of Restricted Stock Unit Activity
The following table summarizes the restricted stock units activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value Number of Shares Weighted Average Grant Date Fair Value
Outstanding at beginning of year 2,143,583  $ 7.12  2,147,183  $ 9.10  4,694,360  $ 4.18 
Granted 678,420  17.45  960,637  4.87  572,104  11.24 
Granted - replacement awards     200,291  4.87  —  — 
Distributed (642,992) 7.31  (1,101,115) 8.58  (3,058,307) 1.95 
Forfeited/canceled (56,185) 9.50  (63,413) 7.31  (60,974) 9.31 
Outstanding at end of year 2,122,826  $ 10.31  2,143,583  $ 7.12  2,147,183  $ 9.10 
Summary of Stock Option Activity
The following table summarizes the stock option activity:
Year Ended December 31,
2021 2020 2019
Number of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price
Outstanding at beginning of year 2,485,808  $ 11.60  563,230  $ 10.42  563,230  $ 10.42 
Granted - replacement awards     2,010,277  11.86  —  — 
Exercised (1,457,495) 10.36  (79,973) 7.01  —  — 
Forfeited/canceled (26,253) 36.48  (7,726) 41.04  —  — 
Outstanding at end of year 1,002,060  $ 12.75  2,485,808  $ 11.60  563,230  $ 10.42 
Exercisable at end of year 904,574  $ 13.35  2,172,052  $ 11.86  563,230  $ 10.42 
Summary of Grants of Restricted and/or Deferred Shares to Nonemployee Directors
For the last three years, grants of restricted and/or deferred shares have been awarded to elected or re-elected nonemployee directors as follows:
Year of Grant Restricted Shares Deferred Shares
2021 58,851  13,078 
2020 253,809  54,794 
2019 86,477  23,659